⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TAK News
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Alira Health Opens the Registration for the Third Edition of the Global Payer Forum
globenewswire.com
TAK
Takeda Reports Third-Quarter FY2025 Results: Updates Full Year Outlook to Reflect VYVANSE ® Generics Impact, OPEX Discipline and FX Tailwind; Progressing Toward Three Transformative Launches Ahead
businesswire.com
TAK
Exosome Therapy Market Projected to Reach US$ 309.60 Billion by 2035, Supported by Clinical Translation and Manufacturing Scale-Up Says Astute Analytica
globenewswire.com
TAK
JAZZ
Blood Plasma Derivatives Market to Reach USD 47.85 Billion by 2032 with a CAGR of 6.77%
globenewswire.com
EBS
GRFS
TAK
Takeda Announces U.S. Availability of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content 1
businesswire.com
TAK
Global Sleep Apnea Devices Market is Expected to Cross the USD 15 Billion Mark by 2032 | DelveInsight
globenewswire.com
LULU
LLY
AXSM
JAZZ
TAK
AVDL
RMD
VNDA
INSM
Global Sleep Apnea Devices Market is Expected to Cross the USD 15 Billion Mark by 2032 | DelveInsight
globenewswire.com
LULU
LIVN
AXSM
TAK
JAZZ
VNDA
LLY
AVDL
Oncolytics Biotech® Appoints John McAdory as EVP of Strategy and Operations and Yujun Wu to Lead Biostatistics
globenewswire.com
ONCY
CGON
TAK
Macrophage Activation Syndrome Market in the 6MM to Witness Upsurge in Growth at a CAGR of 24.7% During the Forecast Period (2025-2034) | DelveInsight
prnewswire.com
NVS
BIIB
VTRS
UCB
BMY
ABBV
REGN
SNY
LLY
JNJ
HOPE
GCBC
AMGN
TAK
Peptide Therapeutics Market Trends and Global Forecasts to 2040 - Investments Exceeding $7 Billion from Public and Private Sectors Reflect Burgeoning Interest and Potential Returns
globenewswire.com
APLS
BLRX
LLY
NVO
TAK